Results 91 to 100 of about 21,252 (207)

Acute Intermittent Porphyria Triggered by COVID‐19 Mimicking Guillain–Barré Syndrome: A Diagnostic Challenge

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Acute intermittent porphyria (AIP) is a rare heme biosynthesis disorder in which the accumulation of neurotoxic porphyrin precursors precipitates neurovisceral attacks. Intercurrent infections, including coronavirus disease 2019 (COVID‐19), may trigger or exacerbate AIP and complicate diagnosis, as clinical manifestations can resemble those of
Payman Sadeghi   +5 more
wiley   +1 more source

Sensitive and selective spectrophotometric determination of pantoprazole sodium in pharmaceuticals using permanganate [PDF]

open access: yes, 2010
A simple visible spectrophotometric method is described for the determination of pantoprazole sodium sesquihydrate (PSS). The method is based on the formation of a brown colored product on treating PSS with permanganate in neutral medium, the absorbance ...
K. B. VINAY   +2 more
core  

ИСПОЛЬЗОВАНИЕ ИНГИБИТОРОВ ПРОТОННОЙ ПОМПЫ ДЛЯ ЛЕЧЕНИЯ КИСЛОТОЗАВИСИМЫХ ЗАБОЛЕВАНИЙ

open access: yesАрхивъ внутренней медицины, 2013
Proton pump inhibitors take the leading place in treatment of acid-related diseases of the digestive system. Compared to other proton pump inhibitors pantoprazole (Controloc) has higher chemical stability and less potential for interaction with hepatic ...
Л. Б. Лазебник   +2 more
doaj   +1 more source

Profuse nocturnal eyelid haemorrhage from a spider angioma

open access: yes
Acta Ophthalmologica, EarlyView.
Ype P. de Jong, Paulus T. V. M. de Jong
wiley   +1 more source

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1371-1381, May 2026.
The World Health Organization Model Essential Medicines List and African national essential medicines lists (EMLs) detail drugs intended to be consistently available within national health systems, thereby supporting clinicians and pharmacists in making evidence‐based treatment decisions.
Tinashe A. Mazhindu   +5 more
wiley   +1 more source

Proton Pump Inhibitors Therapy in Children with Gastroesophageal Reflux [PDF]

open access: yes, 2013
Proton pump inhibitors (PPI) has been widely used by clinicians to treat diseases that require suppression of gastric acid. PPI work by inhibiting the proton pump in gastric parietal cells.In adult patients, PPI hasbeen widely studied and showed ...
Hegar, B. (Badriul), Reynaldo, A. (Aldo)
core  

Post-sternotomy pain syndrome following cardiac surgery. case report [PDF]

open access: yes, 2017
Over 2 million people undergo sternotomy worldwide for heart surgery each year, and many develop post-sternotomy pain syndrome (PSPS) which persists in the anterior thorax.
Bordoni, Bruno   +4 more
core   +2 more sources

Protective Effect of Asacol in Combination with Pantoprazole in Ulcerative Colitis Patients Who Defecate Asacol Tablets Intactly: A Clinical Trial Study

open access: yesClinical and Experimental Gastroenterology, 2020
Homayoon Bashiri,1,2 Arezoo Bozorgomid1 1Infectious Diseases Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; 2Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranCorrespondence: Arezoo
Bashiri H, Bozorgomid A
doaj  

Pantoprazole-related Symptomatic Hyponatremia

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2016
Hyponatremia is the most common electrolyte balance disorder, especially in the elderly and polymedicated population. The authors report the case of an 83-year-old man with symptomatic severe hyponatremia due to Syndrome of Inappropriate Antidiuretic ...
Filipa Ferreira   +4 more
doaj   +1 more source

Population Pharmacokinetic Modeling and Exposure‐Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 5, May 2026.
ABSTRACT Nemtabrutinib is a Bruton's tyrosine kinase (BTK) inhibitor under clinical investigation in patients with hematologic malignancies, including chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). Nemtabrutinib plasma concentration data from 578 patients enrolled in phase 1 and 2 clinical studies, treated with doses from 5 to ...
Chiara C. Kemal   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy